mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |